Background/Aims: Postmenopausal osteoporosis is closely associated with reduction in the differentiation of mesenchymal stem cells (MSCs) into osteoblasts. Previous studies have demonstrated that miR-214 plays an important role in the genesis and development of postmenopausal osteoporosis. Here, we performed this study to investigate the potential mechanism by which miR-214 regulates osteoblast differentiation of MSCs. Methods: First, we explored the expression of miR-214 in MSCs of osteoporotic mice. Next, we examined the change of miR-214 during osteoblast differentiation of MSCs. Then, MSCs were infected with lentiviral vectors expressing miR-214 or miR-214 sponge to investigate the effect of miR-214 on osteoblast differentiation of MSCs. Further, bioinformatics analysis and luciferase reporter assay were performed to identify and validate the target gene of miR-214. Results: MiR-214 was up-regulated in MSCs of osteoporotic mice and down-regulated during osteoblast differentiation of MSCs. Furthermore, overexpression of miR-214 inhibited osteoblast differentiation of MSCs in vitro, whereas inhibition of miR-214 function promoted this process, evidenced by increased expression of osteoblast-specific genes, alkaline phosphatase (ALP) activity, and matrix mineralization. Bioinformatics, Western blot analysis and luciferase reporter assay demonstrated that FGFR1 is a direct target of miR-214. Conclusions: MiR-214 attenuates osteogenesis by inhibiting the FGFR1/FGF signaling pathway. Our findings suggest that targeting miR-214 promises to be a potential therapy in treatment of postmenopausal osteoporosis.
MiR

Introduction
Estrogen deficiency-induced postmenopausal osteoporosis is a common disease characterized by low bone mineral density (BMD) and low trauma fractures, mainly resulting from exceeding bone resorption by osteoclasts over bone formation by osteoblasts [1] [2] [3] .
Mesenchymal stem cells (MSCs) are a population of self-renewing multipotent cells that have significant clinical potential in cellular therapies for tissue regeneration [4, 5] .
MSCs are progenitor cells of osteoblasts and osteocytes in bone formation [6] . A reduction in the differentiation of MSCs into osteoblasts contributes to the impaired bone formation observed in osteoporosis [7] .
MicroRNAs (miRNAs) are a growing class of small (~22 nucleotides), single-stranded noncoding RNAs and negatively regulate translation of specific mRNAs by base pairing to the 3' untranslated regions (3'UTR) [8] [9] [10] . Previous studies have demonstrated that miRNAs played an important role in the development of osteoporosis [11] [12] [13] [14] [15] [16] .
In recent years, there have been researches focusing on the correlation of miR-214 with bone formation [17] [18] [19] . Among, one study demonstrated that miR-214 directly targeted ATF4 to inhibit osteoblast activity [17] . Another study explored the effects of miR-214 in C2C12 myoblast cells and found that miR-214 inhibits osteogenic differentiation of C2C12 myoblast cells via targeting Osterix (OSX) [18] . Watanabe T et al. suggested that miR-214 not only participates in skeleton formation, but also maintains the skeleton in a healthy state as well [19] . However, expression and function of miR-214 in MSCs remain unclear. The purpose of the present study was to investigate the effects and potential mechanisms of miR-214 in osteogenic differentiation of MSCs.
Materials and Methods
Establishment of osteoporotic models
Female C57BL/6J mice purchased from Animal center of Nanjing Medical University were maintained under standard animal housing conditions (12-h light, 12-h dark cycles and free access to food and water) and were ovariectomized (n = 3) or sham-operated (n = 3) at 6 months of age. At 3 months after surgery, both sham-operated and ovariectomized mice were scanned using micro-CT (Siemens AG, Germany). Based on the scans, parameters, including bone mineral density (BMD), bone volume relative to tissue volume (BV/TV, %), trabecular thickness (Tb.Th, mm), trabecular number (Tb.N) and trabecular separation (Tb.Sp, mm), were assessed. After validation by micro-CT, bilateral femurs from sham-operated and ovariectomized mice were collected for further isolation of MSCs. All the experimental procedures were approved by the Committees of Animal Ethics and Experimental Safety of Nanjing Medical University.
Isolation and culture of MSCs
Isolation of MSCs from the collected femurs were performed following a previous protocol [20] . Briefly, the bone marrow cells harvested from bilateral femurs (OVX, Sham or Normal mice) were seeded into 100-mm culture dishes, incubated for 3 hours at 37.8°C to allow attachment of adherent cells, and rinsed twice with PBS to remove the nonadherent cells. Isolated murine MSCs (mMSCs) were cultured with DMEM (Sigma) supplemented with 15% FBS (GIBCO), 2 mM L-glutamine, 100 ug/ml penicillin, and 100 ug/ mL streptomycin (Sigma) and formed adherent colonies after 12 to 15 days of culture.
Cells were passaged twice per week at a split ratio of 1:2 or 1:3 before the 10th passage. The cells at passages 3-6 were used for further experiments unless otherwise described. Flow cytometry was applied to detect the following cell surface markers: CD29, CD44, CD34 and CD45.
Osteogenic differentiation of MSCs mMSCs at passage 3 isolated from normal mice(6 -8 weeks old) were used for experiments of osteoblast differentiation. Osteoblast differentiation was induced using standard osteoblast-induction medium (growth medium supplemented with 10 − 8 M dexamethasone, 0.2 mM l-ascorbic acid, 10 mM β-glycerophosphate, and 10 mM 1.25-vitamin D3) [20] and evidenced by increased ALP activity, enhanced Alizarin red staining and increased expression of genes associated with osteoblast differentiation, RUNX2 ,ALP and osteocalcin (OCN), at different days after induction.
Lentiviral vectors and cell infection
Lentiviral vectors expressing miR-214 (LV-miR-214) and miR-214 sponge (LV-miR-214 sponge) generated by GeneChem (Shanghai, China) were employed to infect MSCs, thus inducing overexpression and inhibition of miR-214 in the cells. Lentivirus without miR-214 or miR-214 sponge were served as controls (Empty). Lentivirus at a dose of 1 x 10 7 TU/ml and a multiplicity of infection (MOI) of 10 was used to infect the cells according to manufacturer's instructions. After being incubated with the lentivirus for 8 hours, the cells were then cultured in fresh medium for further experiments.
Cell viability and proliferation
For the cell proliferation assay, mMSCs were seeded on six-well flexible silicone rubber BioFlex plates at a density of 1.0 x 10 4 cells per well for approximately 12 hours at 37°C and 5% CO2 before proceeding with the assay. After attachment, the cells were respectively infected with lentiviral vectors expressing miR-214 or miR-214 sponge.
Then simply add Alamar Blue reagent (Invitrogen, USA) as 10% of the sample volume (i.e., add 10 uL Alamar Blue reagent to 100uL sample) at 0, 24, 48, and 72 hours respectively after infection. After 4 hours of incubation in the dark, a 100uL sample of the medium was transferred into 96-well plates and the absorbance at 570 and 590 nm was measured using a Multiscan UV visible spectrophotometer (Safire2; TECAN, Mannedorf, Switzerland). A non-seeded BioFlex plate with the same medium was used as blanks. Cells infected with empty lentiviral vectors served as control. Results were recorded using fluorescence or absorbance according to the manufacturer's instructions.
miRNA extraction
The total RNA from the collected cells was extracted using the miRNeasy Mini Kit (QIAGEN, USA). Briefly, the cells were collected in a reaction tube, lysed with 700 μl QIAzol and mixed with 140 μl chloroform. After being centrifuged at 12,000g for 15 min at 4°C, the upper aqueous phase was transferred to an RNeasy Mini spin column in a 2-ml collection tube and mixed with 100% ethanol. After being washed with 700 μl Buffer RWT and 500 μl Buffer RPE, the total RNA was collected for real-time PCR analysis.
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)
Total RNA was extracted with TRIzol reagent. Reverse transcription was performed using a PrimeScript RT reagent kit (TaKaRa, Dalian, China). For miRNAs, real-time RT-PCR primers specific for mouse miR-214 and the internal control U6 were purchased from Riobobio. The following primers were used for quantitative RT-PCR detection: U6 (forward: 5′-CGC TTC ACG AAT TTG CGT GTCAT-3′, reverse: 5′-GCT TCG GCA GCA CAT ATA CTA AAAT-3); miR-214 (forward: 5′-AGC CGA CAG CAG GCA CAG ACA-3′, reverse: 5′-GCT TCG GCA GCA CAT ATA CTA AAAT-3′); RUNX2 (forward: 5′-GGA CGA GGC AAG AGT TTCA-3′, reverse: 5′-TGG TGC AGA GTT CAG GGAG-3′); fibroblast growth factor receptor 1 (FGFR1) (forward:5′-ATT CTG TGG TGC CTT CTGA-3′, reverse:5′-TCT GGC CCG ATC TTA CTC-3′); OCN (forward: 5′-GAG GGC AAT AAG GTA GTGAA-3′, reverse: 5′-CAT AGA TGC GTT TGT AGGC-3′); β-actin (forward:5′-AGC CAT GTA CGT TGCTA-3′, reverse:5′-AGT CCG CCT AGA AGCA-3′). Amplification and detection were performed using the SYBR Premix Ex Taq II kit (TaKaRa) and the Applied Biosystems ABI Prism 7500 HT sequence detection system (Applied Biosystems, Darmstadt, Germany), respectively. β-actin and U6 were used as internal control.
Prediction of target gene
We used the programs miRanda, TargetScan and PicTar to predict the potential targets of miR-214. Among the candidate target genes, we found that FGFR-1 has a miR-214 binding site in its 3'UTR which was closely related to the osteoblast signaling pathway.
Luciferase reporter assay
The FGFR1 3′-UTR luciferase reporter vector was purchased from Genechem (Shanghai, China). Sitedirected mutagenesis was performed using the QuickChange Lightning kit (Stratagene, La Jolla, CA, USA). To 
Western blot
Whole cell lysates for western blotting were extracted with lysis buffer and total protein concentration was determined with a protein assay kit (Beyotime) following the manufacturer's instructions. Total protein (20 μg) was boiled for 5 min in 1× loading buffer, chilled on ice, and then separated on 10% SDS-PAGE and transferred to a PVDF membrane (Millipore, Bedford, MA, USA). Non-specific protein interactions were blocked by incubation with 5% fat-free milk in TBST buffer (50 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20, pH 7.6) at 4°C for 1 h. The membranes were incubated overnight with primary antibody in the blocking buffer at 4°C. Unbound antibody was removed by washing in TBST buffer three times (10 min/wash). The membranes were then incubated with horseradish peroxide-conjugated secondary antibody for 1 h at room temperature (RT), followed by washing with TBST buffer three times (10 min/wash). The membranes were developed using ECL according to the manufacturer's protocols (Millipore).
Alizarin Red staining
After being fixed in 4% paraformaldehyde for 10 min, cells were stained with 2% ARS staining reagent (Nanjing Jiancheng Biotech, China) for 15 min and then washed twice with deionized water. The red positions were recognized as calcium deposits.
Alkaline phosphatase staining
Alkaline phosphatase (ALP) presence in the cell layers was assessed as follows. The cultured cells were rinsed with PBS three times and fixed with 4% paraformaldehyde for 10 min. The fixed cells were incubated in 2 ml of ALP staining reagent (Nanjing Jiancheng Biotech, China) for 15 min and then washed twice with deionized water.
ALP activity Assay
After being seeded at a density of 2 x 10 5 cells per well in 24-well plates, cells were treated in different ways (control or infected with empty lentivirus, LV-miR-214 or LV-miR-214 sponge) and induced into osteoblast differentiation. At different days after induction cells were lyzed with a lysis buffer composed of 20 mM Tris-HCl (pH 7.5), 150 mM NaCl and 1% Triton X-100. Intracellular alkaline phosphatase activity was determined by using an ALP activity kit (Nanjing Jiancheng Biotech, China). The protein concentration of cell lysate was determined by using Bradford assay (Bio-Rad, USA) at 595 nm on a microplate spectrophotometer (TECAN, Australia). The specific ALP activity was normalized to the protein concentration. Each experiment was repeated in sextuple.
Statistical analysis
Data are expressed as mean ± SD. Statistical analysis was performed by using the independent samples t-test (SPSS, USA). P < 0.05 was considered statistically significant.
Results
MiR-214 was overexpressed in MSCs of OVX mice
To validate bone loss due to ovariectomy, both sham-mice and OVX-mice were scanned with micro-CT for BMD, BV/TV and Tb.Th , Tb.N , Tb.Sp (Fig. 1A-E) . The results of OVX-mice are consistent with osteoporosis. Then mMSCs were isolated from bone marrow cells in bilateral femurs for both groups and identified by Flow cytometry.
qRT-PCR was then performed to investigate the difference of miR-214 expression in sham-mMSCs and OVX-mMSCs. The results demonstrated a significant overexpression of miR-214 in OVX-mMSCs compared with sham-mMSCs (Fig. 1F) .
MiR-214 was down-regulated during osteoblast differentiation
To investigate the effect of the overexpressed miR-214 in osteoporosis, mMSCs isolated from normal mice were induced to differentiate into osteoblasts and qRT-PCR for miR-214 was performed at days 3, 7, and 14 after induction. The osteoblast phenotype was confirmed by demonstration of increased expression levels of osteogenesis-associated genes (RUNX2 and osteocalcin (OCN) (Fig. 2A) , enhanced Alizarin red staining (Fig. 2B ) and increased alkaline phosphatase activity (Fig. 2C) . The results of qRT-PCR showed that miR-214 was overexpressed during osteoblast differentiation of mMSCs (Fig. 2D) .
MiR-214 inhibited osteoblast differentiation of MSCs
To evaluate the effects of miR-214 on the viability of mMSCs, Alamar Blue assay was performed. The results showed that cell vitality of mMSCs infected with miR-214 or miR-214 sponge was not significantly different from that in cells infected with empty lentiviral vectors, indicating that inhibition or overexpression of miR-214 had no significant effect on proliferation of mMSCs (Fig. 3A) .
To further investigate the biological effect of miR-214 in osteoblast differentiation of mMSCs, the cells were infected with lentiviral vectors expressing miR-214 or miR-214 sponge and then induced to differentiate into osteoblasts. Cells infected with empty lentivirus were also induced to osteoblast differentiation and served as control. Gene expression profiles of miR-214, RUNX2, ALP and OCN in 3 different groups (LV-miR-214, LV-miR-214 sponge and Empty) were determined by qRT-PCR at day 14 after osteogenic induction (Fig. 3B and  C) . ALP activity assay, ALP staining and Alizarin red staining were also performed at day 14 as evidence of osteoblastic differentiation ( Fig. 3D and E) . We found that inhibition of miR-214 significantly promoted osteoblastic differentiation, indicated by higher expression of the osteoblast-specific genes RUNX2, and OC (Fig. 3C) , increased ALP activity (Fig. 3D) , and enhanced in vitro matrix mineralization visualized by Alizarin red staining (Fig. 3E) . However, overexpression of miR-214 remarkably attenuated osteoblastic differentiation of mMSCs.
FGFR-1 was a direct target of miR-214
To study the further molecular mechanism by which miR-214 regulates osteoblast differentiation of mMSC, we used databases of miRanda, TargetScan and PicTar to search for potential target genes that have an established function in promoting osteogenesis. Among the candidate osteoblast-associated target genes, we found that FGFR-1 has a miR-214 binding site (7-nt) in its 3'UTR (Fig. 4A) . 
MiR-214 attenuated osteoblast differentiation via suppression of the FGFR-1 downstream pathway
To investigate whether miR-214 negatively regulates osteoblast differentiation of MSCs through suppressing FGFR-1 signaling, we explored the protein levels of FGFR1 downstream molecules, including ERK1/2 and RUNX2, which have been demonstrated to be closely associated with osteogenesis. Results revealed no significant changes in total ERK1/2 and RUNX2 when miR-214 was overexpressed or inhibited. We also assessed phosphorylation of ERK1/2 and Runx2, and Western blot analysis showed markedly decreased phosphorylation of both ERK1/2 and Runx2 in miR-214 overexpressing MSCs, whereas inhibition of miR-214 significantly increased levels of pERK1/2 and pRunx2 (Fig. 5A) . Furthermore, we also explored expression of osterix (OSX), a downstream target molecule of the ERK1/2 pathway, 
Discussion
Postmenopausal osteoporosis, a common age-associated human musculoskeletal disease, which is characterized by decreased bone density and increased risk of fractures, has become a major health burden [21, 22] .
Emerging evidence indicates that miRNAs play crucial roles in skeletal development and maintenance, and animal studies of miRNA-based therapy using miRNA inhibitors or mimics, have revealed the potential of targeting miRNAs as a pharmacological approach [23] [24] [25] . Among the numerous reported bone-related miRNAs, miR-214 is one of the research hotspots. MiR-214 is widely expressed in different tissues and cells and targets different mRNAs to regulate various pathophysiologic processes, such as occurrence of cancer [26] [27] [28] [29] , modulation of immune system [30] , protection of heart from ischemic injury [31] and inhibition of angiogenesis [32] . In recent years, there have been several studies focusing on the association of miR-214 with bone formation. For instance, Zhao et al. found that miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway [33] . To our knowledge, this is the first attempt to investigate the biological effects of miR-214 in osteoblast differentiation of MSCs. In our study, we identified miR-214 as a negative regulator of mMSC osteoblast differentiation. Results revealed that miR-214 was downregulated in mMSCs during osteoblast differentiation and inhibition of miR-214 enhanced osteoblast differentiation of mMSCs, whereas miR-214 overexpression inhibited their osteogenic potential. To demonstrate the potential molecular mechanism by which miR-214 regulates the osteoblast differentiation of mMSCs and its involvement in estrogen deficiency-induced osteoporosis, we searched for potential target genes of miR-214 that were related to the osteogenic signaling pathway. Among those target genes, FGFR1 is one of the main targets which has been reported in other researches and closely associated with bone formation. Previous studies have demonstrated that FGF/ FGFR1 signaling pathway is critical in osteogenesis and activation of FGFR1 signaling promotes osteoblast differentiation of MSCs [34] [35] [36] [37] .
Further, we used luciferase reporter system to identify whether FGFR-1 is the direct target of miR-214. Results revealed that miR-214 regulated the FGFR1 expression by directly targeting the 3'-UTR of FGFR1.To further investigate the potential molecular mechanism, we explored expression of molecules of FGF/FGFR1 downstream pathway. Results suggested that overexpression of miR-214 decreased protein level of FGFR1 and subsequently attenuated activation of FGF/FGFR1 downstream signaling, as shown by decreased phosphorylation of ERK1/2 in mMSCs. Given that previous evidence has demonstrated that activation of the ERK1/2 pathway plays a significant role in osteoblast differentiation due to regulation of Runx2 phosphorylation and subsequently, expression of OSX [38] [39] [40] [41] , we further explored expression of Runx2, pRunx2 and OSX. Interestingly, we found that overexpression of miR-214 significantly decreased phosphorylation of Runx2 and downregulated OSX. All above results indicated that inhibition of osteoblast differentiation by miR-214 is caused by suppression of the FGFR1 downstream pathway (Fig. 6) .
In summary, the results showed that miR-214 functions as a negative regulator of osteogenic differentiation of mMSCs by repressing FGFR1 expression, which in turn, results in suppression of the FGFR1 signaling pathway. Importantly, our results showed that functional inhibition of miR-214 can accelerate osteogenic differentiation of mMSCs, suggesting that approaches targeting miR-214 promise to be a potential therapy in the treatment of postmenopausal osteoporosis. 
